|
Volumn 4, Issue 4, 2006, Pages 426-430
|
Management of Perianal Crohn's Disease
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTIBIOTIC AGENT;
AZATHIOPRINE;
CIPROFLOXACIN;
CYCLOSPORIN;
GRANULOCYTE COLONY STIMULATING FACTOR;
IMMUNOSUPPRESSIVE AGENT;
INFLIXIMAB;
MERCAPTOPURINE;
MESALAZINE;
METHOTREXATE;
METRONIDAZOLE;
MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER;
TACROLIMUS;
THALIDOMIDE;
TUMOR NECROSIS FACTOR ALPHA ANTIBODY;
ANAMNESIS;
ANTIBODY PRODUCTION;
ANUS FISTULA;
ARTICLE;
CLINICAL FEATURE;
CLINICAL TRIAL;
COLONOSCOPY;
COLOSTOMY;
CROHN DISEASE;
DIAGNOSTIC PROCEDURE;
DRUG INDUCED DISEASE;
ENDOSCOPIC ECHOGRAPHY;
HUMAN;
HYPERBARIC OXYGEN;
ILEOSTOMY;
KIDNEY FUNCTION;
META ANALYSIS;
MORBIDITY;
NUCLEAR MAGNETIC RESONANCE IMAGING;
OUTCOME ASSESSMENT;
PARENTERAL NUTRITION;
PRACTICE GUIDELINE;
PROCTITIS;
RISK ASSESSMENT;
SEPSIS;
SURGICAL TECHNIQUE;
SYSTEMATIC REVIEW;
ADULT;
ANTI-BACTERIAL AGENTS;
ANTIBODIES, MONOCLONAL;
CROHN DISEASE;
DIGESTIVE SYSTEM SURGICAL PROCEDURES;
ENDOSONOGRAPHY;
GASTROINTESTINAL AGENTS;
HUMANS;
IMMUNOLOGIC FACTORS;
MAGNETIC RESONANCE IMAGING;
MALE;
PROCTITIS;
|
EID: 33645823865
PISSN: 15423565
EISSN: None
Source Type: Journal
DOI: 10.1016/j.cgh.2006.02.001 Document Type: Article |
Times cited : (25)
|
References (0)
|